Free fatty acids profiles are related to gut microbiota signatures and short-chain fatty acids

Frontiers in Immunology

Volumn 8, Issue JUL, 2017, Pages

  Rodríguez Carrio, Javier ^a   Salazar, Nuria ^a   Margolles, Abelardo ^a   González, Sonia ^b   Gueimonde, Miguel ^a   de los Reyes Gavilán, Clara G ^a   Suárez, Ana ^b  

^a DEPARTMENT OF MICROBIOLOGY AND BIOCHEMISTRY OF DAIRY PRODUCTS   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

Author keywords

Akkermansia; Free fatty acids; Microbiota; Serum lipids; Short chain fatty acids; Subclinical metabolic alterations

Indexed keywords

FATTY ACID; GAMMA INTERFERON; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; SHORT CHAIN FATTY ACID;

ADULT; ARTICLE; BIOCHEMICAL ANALYSIS; BODY MASS; CLUSTER ANALYSIS; FAECALIBACTERIUM; FECES MICROFLORA; FOOD COMPOSITION; FOOD FREQUENCY QUESTIONNAIRE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE SYSTEM; IMMUNOASSAY; INTESTINE FLORA; LACTOBACILLUS; LIPID METABOLISM; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; METABOLIC ACTIVATION; METABOLISM; MICROBIAL POPULATION DYNAMICS; NONHUMAN; NUTRITIONAL ASSESSMENT;

EID: 85025705601     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.00823     Document Type: Article

References (67)

1. Håversen L, Danielsson KN, Fogelstrand L, Wiklund O. Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages. Atherosclerosis (2009) 202:382-93. doi:10.1016/j.atherosclerosis.2008.05.033
2. Schaeffler A, Gross P, Buettner R, Bollheimer C, Buechler C, Neumeier M, et al. Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-kappaB pathway in adipocytes links nutritional signalling with innate immunity. Immunology (2009) 126:233-45. doi:10.1111/j.1365-2567.2008.02892.x
3. Frommer KW, Schäffler A, Rehart S, Lehr A, Müller-Ladner U, Neumann E. Free fatty acids: potential proinflammatory mediators in rheumatic diseases. Ann Rheum Dis (2015) 74:303-10. doi:10.1136/annrheumdis-2013-203755
4. Honda KL, Lamon-Fava S, Matthan NR, Wu D, Lichtenstein AH. EPA and DHA exposure alters the inflammatory response but not the surface expression of Toll-like receptor 4 in macrophages. Lipids (2015) 50:121-9. doi:10.1007/s11745-014-3971-y
5. Hung AM, Booker C, Ellis CD, Siew ED, Graves AJ, Shintani A, et al. Omega-3 fatty acids inhibit the up-regulation of endothelial chemokines in maintenance hemodialysis patients. Nephrol Dial Transplant (2015) 30:266-74. doi:10.1093/ndt/gfu283
6. Miles EA, Thies F, Wallace FA, Powell JR, Hurst TL, Newsholme EA, et al. Influence of age and dietary fish oil on plasma soluble adhesion molecule concentrations. Clin Sci (Lond) (2001) 100:91-100. doi:10.1042/cs1000091
7. Livingstone KM, Givens DI, Jackson KG, Lovegrove JA. Comparative effect of dairy fatty acids on cell adhesion molecules, nitric oxide and relative gene expression in healthy and diabetic human aortic endothelial cells. Atherosclerosis (2014) 234:65-72. doi:10.1016/j.atherosclerosis.2014.02.015
8. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol (2008) 8:349-61. doi:10.1038/nri2294
9. Boden G. Obesity and free fatty acids. Endocrinol Metab Clin North Am (2008) 37:635-46, viii-ix. doi:10.1016/j.ecl.2008.06.007
10. Cao H, Gerhold K, Mayers JR, Wiest MM, Watkins SM, Hotamisligil GS. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell (2008) 134:933-44. doi:10.1016/j.cell.2008.07.048
11. Perreault M, Roke K, Badawi A, Nielsen DE, Abdelmagid SA, El-Sohemy A, et al. Plasma levels of 14:0, 16:0, 16:1n-7, and 20:3n-6 are positively associated, but 18:0 and 18:2n-6 are inversely associated with markers of inflammation in young healthy adults. Lipids (2014) 49:255-63. doi:10.1007/s11745-013-3874-3
12. Aghdassi E, Ma DWL, Morrison S, Hillyer LM, Clarke S, Gladman DD, et al. Alterations in circulating fatty acid composition in patients with systemic lupus erythematosus: a pilot study. JPEN J Parenter Enteral Nutr (2011) 35:198-208. doi:10.1177/0148607110386378
13. Nishi SK, Kendall CWC, Bazinet RP, Bashyam B, Ireland CA, Augustin LSA, et al. Nut consumption, serum fatty acid profile and estimated coronary heart disease risk in type 2 diabetes. Nutr Metab Cardiovasc Dis (2014) 24:845-52. doi:10.1016/j.numecd.2014.04.001
14. Van Hees NJM, Giltay EJ, Geleijnse JM, Janssen N, Van Der Does W. DHA serum levels were significantly higher in celiac disease patients compared to healthy controls and were unrelated to depression. PLoS One (2014) 9:e97778. doi:10.1371/journal.pone.0097778
15. Dai L, Gonalves CMV, Lin Z, Huang J, Lu H, Yi L, et al. Exploring metabolic syndrome serum free fatty acid profiles based on GC-SIM-MS combined with random forests and canonical correlation analysis. Talanta (2015) 135:108-14. doi:10.1016/j.talanta.2014.12.039
16. Wang D-C, Sun C-H, Liu L-Y, Sun X-H, Jin X-W, Song W-L, et al. Serum fatty acid profiles using GC-MS and multivariate statistical analysis: potential biomarkers of Alzheimer's disease. Neurobiol Aging (2012) 33:1057-66. doi:10.1016/j.neurobiolaging.2010.09.013
17. Rodriguez-Carrio J, Alperi-Lopez M, López P, Ballina-Garcia FJ, Suárez A. Non-esterified fatty acids profiling in rheumatoid arthritis: associations with clinical features and Th1 response. PLoS One (2016) 11:e0159573. doi:10.1371/journal.pone.0159573
18. Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature (2012) 489:242-9. doi:10.1038/nature11552
19. Scott KP, Gratz SW, Sheridan PO, Flint HJ, Duncan SH. The influence of diet on the gut microbiota. Pharmacol Res (2013) 69:52-60. doi:10.1016/j.phrs.2012.10.020
20. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes (2008) 57:1470-81. doi:10.2337/db07-1403
21. Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A (2004) 101:15718-23. doi:10.1073/pnas.0407076101
22. Samuel BS, Shaito A, Motoike T, Rey FE, Backhed F, Manchester JK, et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci U S A (2008) 105:16767-72. doi:10.1073/pnas.0808567105
23. Sharon G, Garg N, Debelius J, Knight R, Dorrestein PC, Mazmanian SK. Specialized metabolites from the microbiome in health and disease. Cell Metab (2014) 20:719-30. doi:10.1016/j.cmet.2014.10.016
24. Pizarro C, Arenzana-Rámila I, Pérez-Del-Notario N, Pérez-Matute P, González-Sáiz JM. Plasma lipidomic profiling method based on ultrasound extraction and liquid chromatography mass spectrometry. Anal Chem (2013) 85:12085-92. doi:10.1021/ac403181c
25. Cuervo A, Hevia A, López P, Suárez A, Sánchez B, Margolles A, et al. Association of polyphenols from oranges and apples with specific intestinal microorganisms in systemic lupus erythematosus patients. Nutrients (2015) 7:1301-17. doi:10.3390/nu7021301
26. Centro de Enseñanza Superior de Nutrición Humana y Dietética (CESNID). Tablas de composición de alimentos por medidas caseras de consumo habitual en España. Barcelona: McGraw-Hill Publicaciones y Ediciones la Univ Barcelona (2008)
27. Hevia A, Milani C, López P, Cuervo A, Arboleya S, Duranti S, et al. Intestinal dysbiosis associated with systemic lupus erythematosus. mBio (2014) 5:e01548-14. doi:10.1128/mBio.01548-14
28. Salazar N, López P, Valdés L, Margolles A, Suárez A, Patterson AM, et al. Microbial targets for the development of functional foods accordingly with nutritional and immune parameters altered in the elderly. J Am Coll Nutr (2013) 32:399-406. doi:10.1080/07315724.2013.827047
29. Valdés L, Gullón P, Salazar N, Rios-Covián D, González-Muñoz MJ, Parajó JC, et al. Population dynamics of some relevant intestinal microbial groups in human fecal batch cultures with added fermentable xylooligosaccharides obtained from rice husks. BioResources (2013) 8:2429-41
30. Arboleya S, Binetti A, Salazar N, Fernández N, Solís G, Hernández-Barranco A, et al. Establishment and development of intestinal microbiota in preterm neonates. FEMS Microbiol Ecol (2012) 79:763-72. doi:10.1111/j.1574-6941.2011.01261.x
31. Fernández-Navarro T, Salazar N, Gutiérrez-Díaz I, de Los Reyes-Gavilán CG, Gueimonde M, González S. Different intestinal microbial profile in over-weight and obese subjects consuming a diet with low content of fiber and antioxidants. Nutrients (2017) 9:E551. doi:10.3390/nu9060551
32. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, et al. Human gut microbiome viewed across age and geography. Nature (2012) 486:222-7. doi:10.1038/nature11053
33. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, et al. Diversity of the human intestinal microbial flora. Science (2005) 308:1635-8. doi:10.1126/science.1110591
34. Derrien M, Belzer C, de Vos WM. Akkermansia muciniphila and its role in regulating host functions. Microb Pathog (2016) 106:171-81. doi:10.1016/j.micpath.2016.02.005
35. Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A (2013) 110:9066-71. doi:10.1073/pnas.1219451110
36. Schneeberger M, Everard A, Gómez-Valadés AG, Matamoros S, Ramírez S, Delzenne NM, et al. Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Sci Rep (2015) 5:16643. doi:10.1038/srep16643
37. Caesar R, Tremaroli V, Kovatcheva-Datchary P, Cani PD, Bäckhed F. Crosstalk between gut microbiota and dietary lipids aggravates WAT inflammation through TLR signaling. Cell Metab (2015) 22:658-68. doi:10.1016/j.cmet.2015.07.026
38. Dao MC, Everard A, Aron-Wisnewsky J, Sokolovska N, Prifti E, Verger EO, et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut (2016) 65:426-36. doi:10.1136/gutjnl-2014-308778
39. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes (2007) 56:1761-72. doi:10.2337/db06-1491
40. Lim MY, You HJ, Yoon HS, Kwon B, Lee JY, Lee S, et al. The effect of heritability and host genetics on the gut microbiota and metabolic syndrome. Gut (2016) 66:1031-8. doi:10.1136/gutjnl-2015-311326
41. Png CW, Lindén SK, Gilshenan KS, Zoetendal EG, McSweeney CS, Sly LI, et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am J Gastroenterol (2010) 105:2420-8. doi:10.1038/ajg.2010.281
42. Zhang X, Shen D, Fang Z, Jie Z, Qiu X, Zhang C, et al. Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One (2013) 8:e71108. doi:10.1371/journal.pone.0071108
43. Leutner M, Göbl C, Wielandner A, Howorka E, Prünner M, Bozkurt L, et al. Clinical and metabolic characteristics of treated hyperlipidemic patients additionally affected by subclinical hyperglycemia. Lipids Health Dis (2016) 15:10. doi:10.1186/s12944-016-0180-0
44. Viscogliosi G, Andreozzi P, Marigliano V. Associations of plasma glucose levels and traits of metabolic syndrome with carotid intima media thickness in nondiabetic elderly subjects: are they mediated by insulin resistance? Metab Syndr Relat Disord (2013) 11:41-5. doi:10.1089/met.2012.0087
45. Fontbonne A, Eschwège E, Cambien F, Richard JL, Ducimetière P, Thibult N, et al. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia (1989) 32:300-4. doi:10.1007/BF00265546
46. Fontbonne A, Thibult N, Eschwège E, Ducimetière P. Body fat distribution and coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes mellitus: the Paris Prospective Study, 15-year follow-up. Diabetologia (1992) 35:464-8. doi:10.1007/BF02342445
47. Levitan EB, Song Y, Ford ES, Liu S. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? Arch Intern Med (2004) 164:2147. doi:10.1001/archinte.164.19.2147
48. Pistrosch F, Natali A, Hanefeld M. Is hyperglycemia a cardiovascular risk factor? Diabetes Care (2011) 34:S128-31. doi:10.2337/dc11-s207
49. Armougom F, Henry M, Vialettes B, Raccah D, Raoult D. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and methanogens in anorexic patients. PLoS One (2009) 4:e7125. doi:10.1371/journal.pone.0007125
50. Million M, Angelakis E, Maraninchi M, Henry M, Giorgi R, Valero R, et al. Correlation between body mass index and gut concentrations of Lactobacillus reuteri, Bifidobacterium animalis, Methanobrevibacter smithii and Escherichia coli. Int J Obes (Lond) (2013) 37:1460-6. doi:10.1038/ijo.2013.20
51. Million M, Maraninchi M, Henry M, Armougom F, Richet H, Carrieri P, et al. Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. Int J Obes (Lond) (2012) 36:817-25. doi:10.1038/ijo.2011.153
52. Million M, Thuny F, Angelakis E, Casalta J-P, Giorgi R, Habib G, et al. Lactobacillus reuteri and Escherichia coli in the human gut microbiota may predict weight gain associated with vancomycin treatment. Nutr Diabetes (2013) 3:e87. doi:10.1038/nutd.2013.28
53. Zeng H, Liu J, Jackson MI, Zhao F-Q, Yan L, Combs GF. Fatty liver accompanies an increase in Lactobacillus species in the hind gut of C57BL/6 mice fed a high-fat diet. J Nutr (2013) 143:627-31. doi:10.3945/jn.112.172460
54. Consolandi C, Turroni S, Emmi G, Severgnini M, Fiori J, Peano C, et al. Behçet's syndrome patients exhibit specific microbiome signature. Autoimmun Rev (2015) 14:269-76. doi:10.1016/j.autrev.2014.11.009
55. Wang J, Tang H, Zhang C, Zhao Y, Derrien M, Rocher E, et al. Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME J (2015) 9:1-15. doi:10.1038/ismej.2014.99
56. Tran THT, Boudry C, Everaert N, Théwis A, Portetelle D, Daube G, et al. Adding mucins to an in vitro batch fermentation model of the large intestine induces changes in microbial population isolated from porcine feces depending on the substrate. FEMS Microbiol Ecol (2016) 92:fiv165. doi:10.1093/femsec/fiv165
57. Alard J, Lehrter V, Rhimi M, Mangin I, Peucelle V, Abraham A-L, et al. Beneficial metabolic effects of selected probiotics on diet-induced obesity and insulin resistance in mice are associated with improvement of dysbiotic gut microbiota. Environ Microbiol (2016) 18:1484-97. doi:10.1111/1462-2920.13181
58. Belzer C, de Vos WM. Microbes inside-from diversity to function: the case of Akkermansia. ISME J (2012) 6:1449-58. doi:10.1038/ismej.2012.6
59. Derrien M, Van Baarlen P, Hooiveld G, Norin E, Müller M, de Vos WM. Modulation of mucosal immune response, tolerance, and proliferation in mice colonized by the mucin-degrader Akkermansia muciniphila. Front Microbiol (2011) 2:166. doi:10.3389/fmicb.2011.00166
60. Ferreira LD, Pulawa LK, Jensen DR, Eckel RH. Overexpressing human lipoprotein lipase in mouse skeletal muscle is associated with insulin resistance. Diabetes (2001) 50:1064-8. doi:10.2337/diabetes.50.5.1064
61. Kim JK, Fillmore JJ, Chen Y, Yu C, Moore IK, Pypaert M, et al. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci U S A (2001) 98:7522-7. doi:10.1073/pnas.121164498
62. Shin N-R, Lee J-C, Lee H-Y, Kim M-S, Whon TW, Lee M-S, et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut (2014) 63:727-35. doi:10.1136/gutjnl-2012-303839
63. Lukovac S, Belzer C, Pellis L, Keijser BJ, de Vos WM, Montijn RC, et al. Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids. mBio (2014) 5(4):e01438-14. doi:10.1128/mBio.01438-14
64. BrestoffJR, Artis D. Commensal bacteria at the interface of host metabolism and the immune system. Nat Immunol (2013) 14:676-84. doi:10.1038/ni.2640
65. Ríos-Covián D, Ruas-Madiedo P, Margolles A, Gueimonde M, de Los Reyes-Gavilán CG, Salazar N. Intestinal short chain fatty acids and their link with diet and human health. Front Microbiol (2016) 7:185. doi:10.3389/fmicb.2016.00185
66. Salazar N, Dewulf EM, Neyrinck AM, Bindels LB, Cani PD, Mahillon J, et al. Inulin-type fructans modulate intestinal Bifidobacterium species populations and decrease fecal short-chain fatty acids in obese women. Clin Nutr (2015) 34:501-7. doi:10.1016/j.clnu.2014.06.001
67. Vrieze A, Holleman F, Zoetendal EG, de Vos WM, Hoekstra JBL, Nieuwdorp M. The environment within: how gut microbiota may influence metabolism and body composition. Diabetologia (2010) 53:606-13. doi:10.1007/s00125-010-1662-7